Catalent logo
Catalent logo

Catalent

catalent.com
catalent.com • HQ: Somerset, United States • Venture - Series Unknown 2019 • 1001-5000 employees
HQ: Somerset, United States • Venture - Series Unknown 2019 • 1001-5000 employees
Actively hiring
Health Care
APIs & Drug Manufacturing
Biotechnology
As featured in
Ad Hoc News
businesswire
Chemistry World
The Wall Street Journal
CNBC
Fiercepharma
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Catalent is a leading global CDMO for pharma, biotech and consumer health, from development through commercial supply. Explore our solutions.

News

News Catalent stock gains after FDA clears key manufacturing site 8 days ago
Catalent stock gains after FDA clears key manufacturing site
Catalent stock reacts to an FDA compliance decision on September 19, 2026, that lifts uncertainty over a major biologics facility. The company's latest quarterly figures show revenue growth and margin pressure investors are watching closely.
Read more
Report
Press release businesswire.com 11 months ago
Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by "Championing the Missions that Matter" Read more
Report
News Chemistry World 2 years ago
Novo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
Read more
Report
News wsj.com 2 years ago
Wegovy Maker to Boost Production Capacity with Multibillion-Dollar Deal Read more
Report
News CNBC 3 years ago
Activist Elliott makes inroads at Catalent to build value. Here's what could happen next
Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the pharmaceutical company.
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

John Chiminski
Executive Officer, Director
SEC Form D
Wetteny Joseph
Executive Officer
SEC Form D
Alessandro Maselli
Executive Officer
SEC Form D
Steven Fasman
Executive Officer
SEC Form D
Jack Stahl
Director
SEC Form D
Madhavan Balachandran
Director
SEC Form D
J. Carroll
Director
SEC Form D
Rolf Classon
Director
SEC Form D
Rosemary Crane
Director
SEC Form D
John Greisch
Director
SEC Form D
Christa Kreuzburg
Director
SEC Form D
Gregory Lucier
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Somerset United States
HQ
1000-5000 est. staff

Financials

Total raised
$650M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2019 $650M Details